YmAbs Therapeutics (YMAB)
(Delayed Data from NSDQ)
$12.19 USD
-0.09 (-0.73%)
Updated May 13, 2024 04:00 PM ET
After-Market: $12.18 -0.01 (-0.08%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/8/24 |
---|---|
Current Quarter | -0.10 |
EPS Last Quarter | -0.15 |
Last EPS Surprise | -25.00% |
ABR | 1.78 |
Earnings ESP
|
3.22% |
---|---|
Current Year | -0.48 |
Next Year | -0.34 |
EPS (TTM) | -0.49 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 23.68M | 24.55M | 95.36M | 107.79M |
# of Estimates | 3 | 3 | 3 | 2 |
High Estimate | 23.90M | 25.10M | 97.46M | 110.87M |
Low Estimate | 23.40M | 24.26M | 92.60M | 104.70M |
Year ago Sales | 20.75M | 20.45M | 84.82M | 95.36M |
Year over Year Growth Est. | 14.13% | 20.06% | 12.43% | 13.03% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.10 | -0.12 | -0.48 | -0.34 |
# of Estimates | 3 | 3 | 4 | 3 |
Most Recent Consensus | -0.11 | -0.12 | -0.46 | -0.46 |
High Estimate | -0.06 | -0.09 | -0.40 | -0.03 |
Low Estimate | -0.14 | -0.14 | -0.60 | -0.85 |
Year ago EPS | -0.14 | -0.18 | -0.49 | -0.48 |
Year over Year Growth Est. | 28.57% | 33.33% | 2.04% | 27.95% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 0 | 0 | 0 |
Down Last 7 Days | 1 | 2 | 2 | 2 |
Down Last 30 Days | 1 | 2 | 2 | 2 |
Down Last 60 Days | 1 | 2 | 2 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.10 | -0.12 | -0.48 | -0.34 |
7 Days Ago | -0.10 | -0.10 | -0.43 | -0.20 |
30 Days Ago | -0.10 | -0.10 | -0.43 | -0.29 |
60 Days Ago | -0.10 | -0.10 | -0.43 | -0.29 |
90 Days Ago | -0.23 | -0.22 | -0.68 | -0.65 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.10 | -0.12 | -0.50 | -0.34 |
Zacks Consensus Estimate | -0.10 | -0.12 | -0.48 | -0.34 |
Earnings ESP | 3.22% | 1.43% | -4.71% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.15 | -0.02 | -0.18 | -0.14 | NA |
Estimate | -0.12 | -0.19 | -0.16 | -0.24 | NA |
Difference | -0.03 | 0.17 | -0.02 | 0.10 | 0.06 |
Surprise | -25.00% | 89.47% | -12.50% | 41.67% | 23.41% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more